ST. JOSEPH, Mo. — Boehringer Ingelheim has established a new research and development laboratory in St. Joseph Mo. The company recently hosted a ribbon cutting ceremony to demonstrate its new facility and stated that the laboratory will “revolutionize the development of future products, including biotherapeutics.”
Boehringer Ingelheim explained, “this unique late-stage R&D laboratory, the only one of its kind in the US, is designed to streamline the process of transitioning products from development to manufacturing, enhancing our ability to serve animals better. The lab's flexible design and proprietary equipment, which allows scientists to mimic operations, removes hurdles. . .
Register or Login to keep reading
Thank you for your interest in accessing the complete content. To continue reading, please register for free. By registering, you'll gain full access to our valuable resources, updates, and insights.
If you already have an account please Log In.
